Key facts
- This page summarizes Clark Ian T.'s Form 4 filing for AGIOS PHARMACEUTICALS, INC. (AGIO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 May 2022, 16:12.
Clark Ian T. - 20 May 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)
- Reporting relationship
- Director
- Issuer ticker
- AGIO
- Reported as of
- 20 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 May 2022, 16:12:10 UTC
- Prior SEC filing
- 13 Sep 2021
- Next SEC filing
- 10 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Cook, as Attorney-in-fact for Ian Clark
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Clark Ian T. filed Form 4 for AGIOS PHARMACEUTICALS, INC. (AGIO) on 24 May 2022.
Change
- Previous filing in this sequence was filed on 13 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGIO
transaction
Common stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,585
- Change %
- +32%
- Price
- $0.000000
- Shares after
- 6,549
- Date
- 20 May 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGIO
transaction
Derivative
Restricted stock unit
Options Exercise
- Transaction value
- $0
- Shares
- -1,585
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 May 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 1,585
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Footnote F2
The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested